Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biafine is a prominent French skincare brand specializing in topical emulsions for the treatment of burns, wounds, and skin irritations. Originally developed in 1971 by Jean-Marie Yerly for Laboratoire Yerly, the brand became a staple in French pharmacies for its efficacy in promoting skin healing and hydration. Its flagship product, Biafine Emulsion, is widely used for sunburns, radiation-induced dermatitis, and superficial wounds. The formulation works by maintaining a moist environment and facilitating the recruitment of macrophages to the site of injury. Today, the brand is part of Kenvue, the consumer health spin-off from Johnson & Johnson, and continues to be a leader in the dermo-cosmetic and wound care markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biafine.